FunPep Company Limited (4881.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.1x

Market Cap

JPY 1.99B

MomentumView details →

1D Return

+0.00%

YTD Return

−37.80%

RSI (14)

46.4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.1x

Market Cap

JPY 1.99B

RSI (14)

46.4

MomentumView details →

1D Return

+0.00%

YTD Return

−37.80%

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−100.82%

ROA (TTM)

−78.13%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

−100.00%

EPS YoY

+6.73%

FCF YoY

—

Revenue CAGR 3Y

−100.00%

EPS CAGR 3Y

−56.97%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

4.35x

Quick Ratio

4.33x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−1.60B

Op. CF (TTM)

—

Next earningsNov 18, 2026 →

Latest newsMore news →

Fanpep announced on August 14, 2026 that it recorded an impairment loss on investment securities as a special loss for the second quarter of fiscal year ending December 2026.19d ago

Similar companies

Perseus Proteomics Inc.4882.T CHUKYO IYAKUHIN CO.,LTD.4558.T Veritas In Silico Inc.130A.T Delta-Fly Pharma,Inc.4598.T Kringle Pharma,Inc.4884.T SymBio Pharmaceuticals Limited4582.T Find similar companies →

Latest newsMore news →

Fanpep announced on August 14, 2026 that it recorded an impairment loss on investment securities as a special loss for the second quarter of fiscal year ending December 2026.19d ago